Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth

The anti-HER2 antibody Trastuzumab (Herceptin) has been proven to be effective in the treatment of HER2 overexpressing breast cancer; resistance, however invariably emerges in metastatic tumors. The expression of p95-HER2, a form of HER2 with a truncated extracellular domain that lacks the Trastuzum...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Chandarlapaty, Sarat, Scaltriti, Maurizio, Angelini, Pierdavide, Ye, Qing, Guzman, Marta, Hudis, Clifford A., Norton, Larry, Solit, David B., Arribas, Joaquin, Baselga, Jose, Rosen, Neal
格式: Artigo
語言:Inglês
出版: 2009
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC3057066/
https://ncbi.nlm.nih.gov/pubmed/19855434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2009.337
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍